Blackbaud (BLKB) vs Cellebrite DI (CLBT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Blackbaud (BLKB) has outperformed Cellebrite DI (CLBT) over the past year, losing 13.6% versus a loss of 36.2%. Over five years, CLBT leads with a +24.1% price change compared with -37.0% for BLKB. Cellebrite DI is the larger company by market cap ($2.71 billion vs $2.20 billion), about 1.2 times the size.
On valuation, Blackbaud trades at a lower forward P/E (8.1x vs 16.1x for Cellebrite DI). Cellebrite DI converts more of its revenue into profit, with a net margin of 16.5% versus 10.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLKB | CLBT |
|---|---|---|
| Share price | $48.83 | $10.77 |
| Market cap | $2.20B | $2.71B |
| 1-day change | -0.39% | -4.86% |
| YTD return | -22.88% | -40.27% |
| 1-year return | -13.56% | -36.20% |
| 5-year return | -37.00% | +24.08% |
| P/E ratio (TTM) | 15.02 | 43.08 |
| Forward P/E | 8.14 | 16.09 |
| EPS (TTM) | $3.25 | $0.25 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.13B | $475.68M |
| Revenue growth (YoY) | -2.27% | +18.56% |
| Net income (latest FY) | $114.97M | $78.33M |
| Gross margin | 58.78% | 84.20% |
| Operating margin | 16.91% | 13.98% |
| Net margin | 10.19% | 16.47% |
| 52-week high | $64.84 | $19.39 |
| 52-week low | $25.58 | $9.58 |
| Distance from 52-week high | -24.69% | -44.46% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +15.20% | +43.27% |
| Average volume | 421.21K | 2.35M |
| Shares outstanding | 44.98M | 251.34M |
| Employees | 2,800 | 1,285 |
| Sector | Technology | Technology |
| Industry | Computer Software: Prepackaged Software | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BLKB has outperformed CLBT by 22.6 percentage points over the past year.
- Cellebrite DI trades at a higher earnings multiple (43.1x vs 15.0x trailing P/E).
- Cellebrite DI is more profitable, keeping 16.5 cents of every revenue dollar as net income versus 10.2 cents for Blackbaud.
- Cellebrite DI grew revenue faster in its latest fiscal year (+18.56% vs -2.27%).
About Blackbaud
BLKB stock →Blackbaud, Inc. engages in the providing AI-powered solutions in the United States and internationally.
Technology · Computer Software: Prepackaged Software · 2,800 employees
About Cellebrite DI
CLBT stock →Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
Technology · Computer Software: Prepackaged Software · 1,285 employees
BLKB vs CLBT FAQ
Which is bigger, Blackbaud or Cellebrite DI?
Cellebrite DI (CLBT) is larger, with a market capitalization of $2.71B compared with $2.20B for Blackbaud (BLKB).
Which stock has performed better over the past year, BLKB or CLBT?
BLKB returned -13.56% over the past 12 months, compared with -36.20% for CLBT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BLKB or CLBT?
BLKB has the lower trailing P/E at 15.0, versus 43.1 for CLBT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Blackbaud and Cellebrite DI in the same industry?
Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.